367
Views
2
CrossRef citations to date
0
Altmetric
Review

Herbal Anxiolytics: Sources and Their Preparation Methods

ORCID Icon & ORCID Icon

References

  • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th ed.; American Psychiatric Association: Arlington, VA, 2013.
  • Barlow, D. H. Anxiety and Its Disorders :The Nature and Treatment of Anxiety and Panic; Guilford Press: New York, 2002.
  • Camfield, D.; McIntyre, E. and Sarris, J., Eds. Evidence-Based Herbal and Nutritional Treatments for Anxiety in Psychiatric Disorders; Springer International Publishing: Cham, 2017.
  • Fedotova, J.; Kubatka, P.; Büsselberg, D.; Shleikin, A. G.; Caprnda, M.; Dragasek, J.; Rodrigo, L.; Pohanka, M.; Gasparova, I.; Nosal, V., et al. Therapeutical Strategies for Anxiety and Anxiety-Like Disorders Using Plant-Derived Natural Compounds and Plant Extracts. Biomed. Pharmacother. 2017, 95, 437–446. DOI: 10.1016/j.biopha.2017.08.107.
  • Alramadhan, E.; Hanna, M. S.; Hanna, M. S.; Goldstein, T. A.; Avila, S. M.; Weeks, B. S. Dietary and Botanical Anxiolytics. Med. Sci. Monit. 2012, 18(4), RA40–RA48. DOI: 10.12659/MSM.882608.
  • Martin, E. I.; Ressler, K. J.; Binder, E.; Nemeroff, C. B. The Neurobiology of Anxiety Disorders: Brain Imaging, Genetics, and Psychoneuroendocrinology. Psychiatry Clin. N. Am. 2009, 32(3), 549–575. DOI: 10.1016/j.psc.2009.05.004.
  • Sareen, J.; Jacobi, F.; Cox, B. J.; Belik, S.-L.; Clara, I., and Stein, M. B. Disability and Poor Quality of Life Associated with Comorbid Anxiety Disorders and Physical Conditions. Arch. Int. Med. 2006, 166(19), 2109–2116. DOI: 10.1001/archinte.166.19.2109.
  • Ringbäck Weitoft, G.; Rosén, M. Is Perceived Nervousness and Anxiety a Predictor of Premature Mortality and Severe Morbidity? A Longitudinal Follow Up of the Swedish Survey of Living Conditions. J. Epidemiol. Community Health. 2005, 59(9), 794–798. DOI: 10.1136/jech.2005.033076.
  • Kaur, S.; Sharma, A.; Bedi, P. M. S. Bioactivity Guided Isolation, Characterization and Quantification of an Anxiolytic Constituent - Kaempferol, from Melilotus Officinalis Aerial Parts. J. Biol. Act. Prod. Nat. 2017, 7(5), 379–390. DOI: 10.1080/22311866.2017.1378923.
  • Gulati, K.; Rai, N.; Ray, A. Chapter Seven - Nitric Oxide and Anxiety. In Vitamins and Hormones; Litwack, G., Ed.; Anxiety; Academic Press: Cambridge, MA. 2017; Vol. 103, pp. 169–192.
  • Ray, A.; Gulati, K.; Rai, N. Chapter One - Stress, Anxiety, and Immunomodulation: A Pharmacological Analysis. In Vitamins and Hormones; Litwack, G., Ed.; Anxiety; Academic Press: Cambridge, MA. 2017; Vol. 103, pp. 1–25.
  • Saki, K.; Bahmani, M.; Rafieian-Kopaei, M. The Effect of Most Important Medicinal Plants on Two Importnt Psychiatric Disorders (Anxiety and Depression)-a Review. Asian Pac. J. Trop. Med. 2014, 7, S34–S42. DOI: 10.1016/S1995-7645(14)60201-7.
  • Public Health Agency of Canada. Report from the Canadian Chronic Disease Surveillance System: Mood and Anxiety Disorders in Canada, 2016. https://www.canada.ca/en/public-health/services/publications/diseases-conditions/report-canadian-chronic-disease-surveillance-system-mood-anxiety-disorders-canada-2016.html (accessed Aug 20, 2019).
  • Blessing, E. M.; Steenkamp, M. M.; Manzanares, J.; Marmar, C. R. Cannabidiol as a Potential Treatment for Anxiety Disorders. Neurotherapeutics. 2015, 12, 825–836. DOI: 10.1007/s13311-015-0387-1.
  • Schmidt, C. K.; Khalid, S.; Loukas, M., and Tubbs, R. S. Neuroanatomy of Anxiety: A Brief Review. Cureus. 2018, 10 1–8 .
  • Etkin, A. Functional Neuroanatomy of Anxiety: A Neural Circuit Perspective. In Behavioral Neurobiology of Anxiety and Its Treatment 2 ; Stein, M.B., and Steckler, T., Eds.; Current Topics in Behavioral Neurosciences; Springer: Berlin, Heidelberg, 2009, pp. 251–277.
  • Schienle, A., and Wabnegger, A. Structural and Functional Neuroanatomy of Generalized Anxiety Disorder. In Generalized Anxiety Disorder and Worrying: A Comprehensive Handbook for Clinicians and Researchers Gerlach, Alexander L., and Gloster, Andrew T.; John Wiley & Sons, Ltd: Hoboken, NJ, 2020; pp. 151–171.
  • Sadock, B.; Sadock, V. A.; Ruiz, P. Kaplan and Sadock’s Concise Textbook of Clinical Psychiatry; Wolters Kluwer: Hagerstown, United States, 2017.
  • Won, E., and Kim, Y.-K. Neuroinflammation-Associated Alterations of the Brain as Potential Neural Biomarkers in Anxiety Disorders. Int. J. Mol. Sci. 2020, 21(18), 6546. DOI: 10.3390/ijms21186546.
  • Bandelow, B.; Michaelis, S., and Wedekind, D. Treatment of Anxiety Disorders. Dialogues Clin. Neurosci. 2017, 19, 93–107.
  • Emilien, G.; Dinan, T.; Lepola, U. M.; Durlach, C. Anxiety Disorders: Pathophysiology and Pharmacological Treatment; Basel: Birkhäuser Basel, 2002.
  • NIMH » Anxiety Disorders. https://www.nimh.nih.gov/health/topics/anxiety-disorders/index.shtml#part_145338 (accessed Dec 12, 2020).
  • Ghinassi, C. W. Anxiety; ABC-CLIO, LLC: Santa Barbara, United States, 2010.
  • Lader, M. Anxiolytics. In Encyclopedia of Stress, 2nd ed.; Fink, G., Ed.; Academic Press: New York, 2007; pp. 240–243.
  • Kinrys, G.; Coleman, E.; Rothstein, E. Natural Remedies for Anxiety Disorders: Potential Use and Clinical Applications. Depression Anxiety. 2009, 26(3), 259–265. DOI: 10.1002/da.20460.
  • Pitsikas, N. Constituents of Saffron (Crocus Sativus L.) as Potential Candidates for the Treatment of Anxiety Disorders and Schizophrenia. Molecules. 2016, 21(3), 303. DOI: 10.3390/molecules21030303.
  • Ströhle, A. New Pharmacological Treatment Approaches for Anxiety Disorders. In Anxiety and Anxiolytic Drugs; Holsboer, F. and Ströhle, A., Eds.; Handbook of Experimental Pharmacology; Springer: Berlin, Heidelberg, 2005, pp. 503–526.
  • Nash, J. R.; Nutt, D. J. Pharmacotherapy of Anxiety. In Anxiety and Anxiolytic Drugs; Holsboer, F. and Ströhle, A., Eds.; Handbook of Experimental Pharmacology; Springer: Berlin, Heidelberg, 2005, pp. 469–501.
  • Muniandy, Y. The Use of Larval Zebrafish (Danio Rerio) Model for Identifying New Anxiolytic Drugs from Herbal Medicine. Zebrafish. 2018, 15(4), 321–339. DOI: 10.1089/zeb.2018.1562.
  • Mennini, T.; Caccia, S.; Garattini, S. Mechanism of Action of Anxiolytic Drugs. In Progress in Drug Research/fortschritte der Arzneimittelforschung/progrès des Recherches Pharmaceutiques; Jucker, E. and Meyer, U., Eds.; Basel: Birkhäuser, 1987; pp. 315–347.
  • Öztürk, M. A., and Hakeem, K. R. Plant and Human Health; Springer: Cham, Switzerland, 2019; Vol. 3.
  • Huffman, J. C., and Alpert, J. E. An Approach to the Psychopharmacologic Care of Patients: Antidepressants, Antipsychotics, Anxiolytics, Mood Stabilizers, and Natural Remedies. Med. Clin. N. Am. 2010, 94(6), 1141–1160. DOI: 10.1016/j.mcna.2010.08.009.
  • Wang, X.; Chen, Y.; Wang, Q.; Sun, L.; Li, G.; Zhang, C.; Huang, J.; Chen, L.; Zhai, H. Support for Natural Small-Molecule Phenols as Anxiolytics. Molecules. 2017, 22(12), 2138. DOI: 10.3390/molecules22122138.
  • Juneja, L. R.; Chu, D.-C.; Okubo, T.; Nagato, Y.; Yokogoshi, H. L-Theanine—Theanine—A Unique Amino Acid of Green Tea and Its Relaxation Effect in Humans. Trends Food Sci. Technol. 1999, 10(6–7), 199–204. DOI: 10.1016/S0924-2244(99)00044-8.
  • Gerbarg, P. L.; Muskin, P. R.; Brown, R. P. Complementary and Integrative Treatments in Psychiatric Practice; American Psychiatric Publishing: Washington, D.C., United States, 2017.
  • Wei, X.-Y.; Yang, J.-Y.; Wang, J.-H.; Wu, C.-F. Anxiolytic Effect of Saponins from Panax Quinquefolium in Mice. J. Ethnopharmacol. 2007, 111, 613–618. DOI: 10.1016/j.jep.2007.01.009.
  • Sarris, J.; McIntyre, E.; Camfield, D. A. Plant-Based Medicines for Anxiety Disorders, Part 2: A Review of Clinical Studies with Supporting Preclinical Evidence. CNS Drugs. 2013, 27(4), 301–319. DOI: 10.1007/s40263-013-0059-9.
  • Mukherjee, P. K.; Rai, S.; Kumar, V.; Mukherjee, K.; Hylands, P. J.; Hider, R. C. Plants of Indian Origin in Drug Discovery. Expert Opin. Drug Discovery. 2007, 2(5), 633–657. DOI: 10.1517/17460441.2.5.633.
  • Andrade, C.; Aswath, A.; Chaturvedi, S. K.; Srinivasa, M.; Raguram, R. A Double-Blind, Placebo-Controlled Evaluation of the Anxiolytic Efficacy Ff an Ethanolic Extract of Withania Somnifera. Indian J. Psychiatry. 2000, 42(3), 295–301.
  • Suntar, I.; Khan, H.; Patel, S.; Celano, R., and Rastrelli, L. An Overview on Citrus Aurantium L.: Its Functions as Food Ingredient and Therapeutic Agent. Oxid. Med. Cell Longev. 2018, 2018, 1–12. DOI: 10.1155/2018/7864269.
  • Akhlaghi, M.; Shabanian, G.; Rafieian-Kopaei, M.; Parvin, N.; Saadat, M., and Akhlaghi, M. Flor de Citrus Aurantium E Ansiedade Pré-operatória. Rev. Bras. Anestesiol. 2011, 61(6), 702–712. DOI: 10.1590/S0034-70942011000600002.
  • Carvalho-Freitas, M. I. R.; Costa, M. Anxiolytic and Sedative Effects of Extracts and Essential Oil from Citrus Aurantium L. Biol. Pharm. Bull. 2002, 25(12), 1629–1633. DOI: 10.1248/bpb.25.1629.
  • Saiyudthong, S.; Marsden, C. A. Acute Effects of Bergamot Oil on Anxiety-Related Behaviour and Corticosterone Level in Rats. Phytotherapy Res. 2011, 25(6), 858–862. DOI: 10.1002/ptr.3325.
  • Saroya, A. S., and Singh, J. Pharmacotherapeutic Potential of Natural Products in Neurological Disorders 1 ; Singapore: Springer, 2018.
  • Crippa, J. A. S.; Derenusson, G. N.; Ferrari, T. B.; Wichert-Ana, L.; Duran, F. L.; Martin-Santos, R.; Simões, M. V.; Bhattacharyya, S.; Fusar-Poli, P.; Atakan, Z., et al. Neural Basis of Anxiolytic Effects of Cannabidiol (CBD) in Generalized Social Anxiety Disorder: A Preliminary Report. J. Psychopharmacol. 2011, 25(1), 121–130. DOI: 10.1177/0269881110379283.
  • Shannon, S.; Lewis, N.; Lee, H.; Hughes, S. Cannabidiol in Anxiety and Sleep: A Large Case Series. Perm. J. 2019, 23. DOI: 10.7812/TPP/18-041.
  • Small, E. Classification of Cannabis Sativa L. in Relation to Agricultural, Biotechnological, Medical and Recreational Utilization. In Cannabis Sativa L. - Botany and Biotechnology; Chandra, S.; Lata, H.; ElSohly, M.A., Eds.; Springer International Publishing: Cham, 2017; pp. 1–62.
  • Tambaro, S.; Bortolato, M. Cannabinoid-Related Agents in the Treatment of Anxiety Disorders: Current Knowledge and Future Perspectives. 2012, 7(1), 25–40. DOI: 10.2174/157488912798842269.
  • Turna, J.; Patterson, B.; Van Ameringen, M. Is Cannabis Treatment for Anxiety, Mood, and Related Disorders Ready for Prime Time? Depression Anxiety. 2017, 34(11), 1006–1017. DOI: 10.1002/da.22664.
  • ElSohly, M. A.; Radwan, M. M.; Gul, W.; Chandra, S.; Galal, A. Phytochemistry of Cannabis Sativa L. In Phytocannabinoids: Unraveling the Complex Chemistry and Pharmacology of Cannabis Sativa; Kinghorn, A.D.; Falk, H.; Gibbons, S. and Kobayashi, J., Eds.; Progress in the Chemistry of Organic Natural Products; Springer International Publishing: Cham, 2017, pp. 1–36.
  • Small, E.; Naraine, S. G. U. Expansion of Female Sex Organs in Response to Prolonged Virginity in Cannabis Sativa (Marijuana). Genet. Resour. Crop Evol. 2016, 63(2), 339–348. DOI: 10.1007/s10722-015-0253-3.
  • Masoumi-Ardakani, Y.; Mahmoudvand, H.; Mirzaei, A.; Esmaeilpour, K.; Ghazvini, H.; Khalifeh, S.; Sepehri, G. The Effect of Elettaria Cardamomum Extract on Anxiety-Like Behavior in a Rat Model of Post-Traumatic Stress Disorder. Biomed. Pharmacother. 2017, 87, 489–495. DOI: 10.1016/j.biopha.2016.12.116.
  • Sengottuvelu, S. Chapter 34 - Cardamom (Elettaria Cardamomum Linn. Maton) Seeds in Health. In Nuts and Seeds in Health and Disease Prevention; Preedy, V.R.; Watson, R.R. and Patel, V.B., Eds.; Academic Press: San Diego, 2011; pp. 285–291.
  • Amsterdam, J. D.; Li, Y.; Soeller, I.; Rockwell, K.; Mao, J. J.; Shults, J. A Randomized, Double-Blind, Placebo-Controlledtrial of Oral Matricaria Recutita (Chamomile) Extract Therapy of Generalizedanxiety Disorder. J. Clin. Psychopharmacol. 2009, 29(4), 378–382. DOI: 10.1097/JCP.0b013e3181ac935c.
  • Bhat, S.; Kaushal, P.; Kaur, M.; Sharma, H. K. Coriander (Coriandrum Sativum L.):Processing, Nutritional and Functional Aspects. Afr. J. Plant Sci. 2014, 8(1), 25–33. DOI: 10.5897/AJPS2013.1118.
  • Emamghoreishi, M.; Khasaki, M.; Fath Aazam, M. Coriandrum Sativum: Evaluation of Its Anxiolytic Effect in the Elevated Plus-Maze. J. Ethnopharmacol. 2005, 96(3), 365–370. DOI: 10.1016/j.jep.2004.06.022.
  • Mahendra, P.; Bisht, S. Anti-Anxiety Activity of Coriandrum Sativum Assessed Using Different Experimental Anxiety Models. Indian J. Pharmacol. 2011, 43(5), 574–577. DOI: 10.4103/0253-7613.84975.
  • Burdock, G. A.; Carabin, I. G. Safety Assessment of Coriander (Coriandrum Sativum L.) Essential Oil as a Food Ingredient. Food Chem. Toxicol. 2009, 47(1), 22–34. DOI: 10.1016/j.fct.2008.11.006.
  • Fajemiroye, J. O.; Martins, J. L. R.; de Brito, A. F.; Galdino, P. M., de Paula, J. R. et al Central Activities of Pimenta Pseudocaryophyllus (Gomes) L.R. Landrum. Int. J. Med. Aromat. Plants. 2012, 2 118–122 .
  • Fajemiroye, J. O.; da Silva, D. M.; de Oliveira, D. R.; Costa, E. A. Treatment of Anxiety and Depression: Medicinal Plants in Retrospect. Fundam. Clin. Pharmacol. 2016, 30(3), 198–215. DOI: 10.1111/fcp.12186.
  • Sharma, P.; Batra, S.; Kumar, A.; Sharma, A. In vivo Antianxiety and Antidepressant Activity of Murraya Paniculata Leaf Extracts. J. Integr. Med. 2017, 15(4), 320–325. DOI: 10.1016/S2095-4964(17)60352-2.
  • Bisong, S.; Okon, U.; Egbung, E.; Abuo, F.; Sanya, O. Effect of Crude Ethanol Leaf-Extract of Murraya Koenigii on Anxiety in Mice. Asian J. Med. Health. 2017, 7(1), 1–9. DOI: 10.9734/AJMAH/2017/36294.
  • Dahiya, J.; Singh, J.; Kumar, A.; Sharma, A. Isolation, Characterization and Quantification of an Anxiolytic Constituent - Mahanimbine, from Murraya Koenigii Linn. Spreng Leaves. J. Ethnopharmacol. 2016, 193, 706–711. DOI: 10.1016/j.jep.2016.10.014.
  • Ratnasooriya, W. D.; Banduwardene, H. R., and Amarasekera, A. S. Anxiolytic Effect of Murraya Koenigii Leaf Extract in Rats. Med. Sci. Res. 1994, 36 427–428 .
  • Barnes, J.; Anderson, L. A.; Gibbons, S.; Phillipson, J. D. Echinacea Species (Echinacea Angustifolia (DC.) Hell., Echinacea Pallida (Nutt.) Nutt., Echinacea Purpurea (L.) Moench): A Review of Their Chemistry, Pharmacology and Clinical Properties. J. Pharm. Pharmacol. 2005, 57, 929–954. DOI: 10.1211/0022357056127.
  • Haller, J.; Hohmann, J.; Freund, T. F. The Effect of Echinacea Preparations in Three Laboratory Tests of Anxiety: Comparison with Chlordiazepoxide. Phytotherapy Res. 2010, 24(11), 1605–1613. DOI: 10.1002/ptr.3181.
  • Haller, J.; Krecsak, L.; Zámbori, J. Double-Blind Placebo Controlled Trial of the Anxiolytic Effects of a Standardized Echinacea Extract. Phytotherapy Res. 2020, 34(3), 660–668. DOI: 10.1002/ptr.6558.
  • Kasper, S.; Gastpar, M.; Müller, W. E.; Volz, H.-P.; Möller, H.-J.; Schläfke, S.; Dienel, A. Lavender Oil Preparation Silexan is Effective in Generalized Anxiety Disorder – a Randomized, Double-Blind Comparison to Placebo and Paroxetine. Int. J. Neuropsychopharmacol. 2014, 17(06), 859–869. DOI: 10.1017/S1461145714000017.
  • Rahmati, B.; Kiasalari, Z.; Roghani, M.; Khalili, M.; Ansari, F. Antidepressant and Anxiolytic Activity of Lavandula Officinalis Aerial Parts Hydroalcoholic Extract in Scopolamine-Treated Rats. Pharm. Biol. 2017, 55(1), 958–965. DOI: 10.1080/13880209.2017.1285320.
  • Chioca, L. R.; Antunes, V. D. C.; Ferro, M. M.; Losso, E. M.; Andreatini, R. Anosmia Does Not Impair the Anxiolytic-Like Effect of Lavender Essential Oil Inhalation in Mice. Life Sci. 2013, 92(20–21), 971–975. DOI: 10.1016/j.lfs.2013.03.012.
  • Assad, T.; Khan, R. A. Effect of Methanol Extract of Trigonella Foenum-Graecum L. Seeds on Anxiety, Sedation and Motor Coordination. Metab. Brain Dis. 2017, 32(2), 343–349. DOI: 10.1007/s11011-016-9914-y.
  • Iyer, M.; Belapurkar, H.; Sherikar, O.; Kasture, S. B. Anxiolytic Activity of Trigonella Foenum-Greacum Seeds. J. Nat. Remedies. 2004, 4, 61–65.
  • Kalshetti, P. B.; Alluri, R.; Mohan, V.; Thakurdesai, P. A. Effects of 4-Hydroxyisoleucine from Fenugreek Seeds on Depression-Like Behavior in Socially Isolated Olfactory Bulbectomized Rats. Pharmacogn. Mag. 2015, 11(44), S388–S396. DOI: 10.4103/0973-1296.168980.
  • Mohan, M.; Banekar, A.; Birdi, T.; Bharambe, P.; Kaul, S.; Patel, A. Nootropic and Anxiolytic Activity of Fenugreek Seeds. J. Nat. Remedies. 2006, 6, 153–156.
  • Herrera-Ruiz, M.; González-Cortazar, M.; Jiménez-Ferrer, E.; Zamilpa, A.; Álvarez, L.; Ramírez, G.; Tortoriello, J. Anxiolytic Effect of Natural Galphimines from Galphimia Glauca and Their Chemical Derivatives. J. Nat. Prod. 2006, 69(1), 59–61. DOI: 10.1021/np050305x.
  • Sharma, A.; Angulo-Bejarano, P. I.; Madariaga-Navarrete, A.; Oza, G.; Iqbal, H.; Cardoso-Taketa, A.; Luisa Villarreal, M. Multidisciplinary Investigations on Galphimia Glauca: A Mexican Medicinal Plant with Pharmacological Potential. Molecules. 2018, 23(11), 2985. DOI: 10.3390/molecules23112985.
  • Herrera-Ruiz, M.; Jiménez-Ferrer, J. E.; De Lima, T. C. M.; Avilés-Montes, D.; Pérez-GarcíGarcíA, D.; González-Cortazar, M.; Tortoriello, J. Anxiolytic and Antidepressant-Like Activity of a Standardized Extract from Galphimia Glauca. Phytomedicine. 2006, 13(1–2), 23–28. DOI: 10.1016/j.phymed.2005.03.003.
  • Herrera-Arellano, A.; Jiménez-Ferrer, E.; Zamilpa, A.; Morales-Valdéz, M.; GarcíGarcíA-Valencia, C.; Tortoriello, J. Efficacy and Tolerability of a Standardized Herbal Product from Galphimia Glauca on Generalized Anxiety Disorder. A Randomized, Double-Blind Clinical Trial Controlled with Lorazepam. Planta Med. 2007, 73(8), 713–717. DOI: 10.1055/s-2007-981539.
  • Jäger, A. K. CNS Disorders. In Ethnopharmacology Heinrich, Michael, and Jäger, Anna K.; John Wiley & Sons, Ltd: Chichester, West Sussex, 2015; pp. 135–145.
  • Ahlemeyer, B.; Krieglstein, J. Neuroprotective Effects of Ginkgo Biloba Extract. Cell. Mol. Life Sci. 2003, 60(9), 1779–1792. DOI: 10.1007/s00018-003-3080-1.
  • Coon, J. T.; Ernst, E. Panax Ginseng: A Systematic Review of Adverse Effects and Drug Interactions. Drug-Safety. 2002, 25(5), 323–344. DOI: 10.2165/00002018-200225050-00003.
  • Yennurajalingam, S.; Reddy, A.; Tannir, N. M.; Chisholm, G. B.; Lee, R. T.; Lopez, G.; Escalante, C. P.; Manzullo, E. F.; Frisbee Hume, S.; Williams, J. L., et al. High-Dose Asian Ginseng (Panax Ginseng) for Cancer-Related Fatigue: A Preliminary Report. Integr. Cancer Ther. 2015, 14(5), 419–427. DOI: 10.1177/1534735415580676.
  • Liu, L.; Liu, C.; Wang, Y.; Wang, P.; Li, Y.; Li, B. Herbal Medicine for Anxiety, Depression and Insomnia. 2015, 13(4), 481–493. DOI: 10.2174/1570159X1304150831122734.
  • Wijeweera, P.; Arnason, J. T.; Koszycki, D.; Merali, Z. Evaluation of Anxiolytic Properties of Gotukola – (Centella Asiatica) Extracts and Asiaticoside in Rat Behavioral Models. Phytomedicine. 2006, 13(9–10), 668–676. DOI: 10.1016/j.phymed.2006.01.011.
  • Chatterjee, M.; Verma, P.; Maurya, R.; Palit, G. Evaluation of Ethanol Leaf Extract of Ocimum Sanctum in Experimental Models of Anxiety and Depression. Pharm. Biol. 2011, 49(5), 477–483. DOI: 10.3109/13880209.2010.523832.
  • Cohen, M. M. Tulsi - Ocimum Sanctum: A Herb for All Reasons. J. Ayurveda. Integr. Med. 2014, 5(4), 251–259. DOI: 10.4103/0975-9476.146554.
  • Mohan, L.; Mv, A., and Kumari, M. Ocimum Sanctum Linn (Tulsi) - an Overview International Journal of Pharmaceutical Sciences Review and Research . 2011, 7 1 , 51–53.
  • Schulz, V.; Hänsel, R.; Tyler, V. E. Central Nervous System. In Rational Phytotherapy: A Physicians’ Guide to Herbal Medicine; Schulz, V.; Hänsel, R. and Tyler, V.E., Eds.; Springer: Berlin, Heidelberg, 2001; pp. 41–106.
  • Benkherouf, A. Y.; Soini, S. L.; Stompor, M.; Uusi-Oukari, M. Positive Allosteric Modulation of Native and Recombinant GABAA Receptors by Hops Prenylflavonoids. Eur. J. Pharmacol. 2019, 852, 34–41. DOI: 10.1016/j.ejphar.2019.02.034.
  • Small, E.; Catling, P. M. Canadian Medicinal Crops; NRC Research Press: Ottawa, Canada, 1998.
  • Zanoli, P.; Rivasi, M.; Zavatti, M.; Brusiani, F.; Baraldi, M. New Insight in the Neuropharmacological Activity of Humulus Lupulus L. J. Ethnopharmacol. 2005, 102(1), 102–106. DOI: 10.1016/j.jep.2005.05.040.
  • Bocquet, L.; Sahpaz, S.; Hilbert, J. L.; Rambaud, C.; Rivière, C. Humulus Lupulus L., a Very Popular Beer Ingredient and Medicinal Plant: Overview of Its Phytochemistry, Its Bioactivity, and Its Biotechnology. Phytochem. Rev. 2018, 17(5), 1047–1090. DOI: 10.1007/s11101-018-9584-y.
  • Upadhyay, G.; Khoshla, S.; Kosuru, R.; Singh, S. Anxiolytic, Antidepressant, and Antistress Activities of the Aqueous Extract of Cinnamomum Tamala Nees and Eberm in Rats. Indian J. Pharmacol. 2016, 48(5), 555–561. DOI: 10.4103/0253-7613.190752.
  • Rabbani, M.; Sajjadi, S. E.; Vaseghi, G.; Jafarian, A. Anxiolytic Effects of Echium Amoenum on the Elevated Plus-Maze Model of Anxiety in Mice. Fitoterapia. 2004, 75(5), 457–464. DOI: 10.1016/j.fitote.2004.04.004.
  • Sayyah, M.; Sayyah, M.; Kamalinejad, M. A Preliminary Randomized Double Blind Clinical Trial on the Efficacy of Aqueous Extract of Echium Amoenum in the Treatment of Mild to Moderate Major Depression. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 2006, 30(1), 166–169. DOI: 10.1016/j.pnpbp.2005.10.005.
  • Sayyah, M.; Boostani, H.; Pakseresht, S.; Malaieri, A. Efficacy of Aqueous Extract of Echium Amoenum in Treatment of Obsessive–compulsive Disorder. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 2009, 33(8), 1513–1516. DOI: 10.1016/j.pnpbp.2009.08.021.
  • Sayyah, M.; Siahpoosh, A.; Khalili, H.; Malayeri, A.; Samaee, H. A Double-Blind, Placebo-Controlled Study of the Aqueous Extract of Echium Amoenum for Patients with General Anxiety Disorder. Iran. J. Pharm. Res. 2012, 11(2), 697–701.
  • Shafaghi, B.; Naderi, N.; Tahmasb, L., and Kamalinejad, M. Anxiolytic Effect of Echium Amoenum L. in Mice. Iran. J. Pharm. Res. 2002, 1 37–41 .
  • Bilia, A. R.; Gallori, S.; Vincieri, F. F. Kava-Kava and Anxiety: Growing Knowledge About the Efficacy and Safety. Life Sci. 2002, 70(22), 2581–2597. DOI: 10.1016/S0024-3205(02)01555-2.
  • Sarris, J.; Kavanagh, D. J.; Byrne, G.; Bone, K. M.; Adams, J.; Deed, G. The Kava Anxiety Depression Spectrum Study (KADSS): A Randomized, Placebo-Controlled Crossover Trial Using an Aqueous Extract of Piper Methysticum. Psychopharmacology. 2009, 205(3), 399–407. DOI: 10.1007/s00213-009-1549-9.
  • Carpenter, J. M.; Jourdan, M. K.; Fountain, E. M.; Ali, Z.; Abe, N.; Khan, I. A.; Sufka, K. J. The Effects of Sceletium Tortuosum (L.) N.E. Br. Extract Fraction in the Chick Anxiety-Depression Model. J. Ethnopharmacol. 2016, 193, 329–332. DOI: 10.1016/j.jep.2016.08.019.
  • Harvey, A. L.; Young, L. C.; Viljoen, A. M.; Gericke, N. P. Pharmacological Actions of the South African Medicinal and Functional Food Plant Sceletium Tortuosum and Its Principal Alkaloids. J. Ethnopharmacol. 2011, 137(3), 1124–1129. DOI: 10.1016/j.jep.2011.07.035.
  • Patnala, S.; Kanfer, I. Investigations of the Phytochemical Content of Sceletium Tortuosum Following the Preparation of “Kougoed” by Fermentation of Plant Material. J. Ethnopharmacol. 2009, 121(1), 86–91. DOI: 10.1016/j.jep.2008.10.008.
  • Terburg, D.; Syal, S.; Rosenberger, L. A.; Heany, S.; Phillips, N.; Gericke, N.; Stein, D. J.; van Honk, J. Acute Effects of Sceletium Tortuosum (Zembrin), a Dual 5-HT Reuptake and PDE4 Inhibitor, in the Human Amygdala and Its Connection to the Hypothalamus. Neuropsychopharmacology. 2013, 38(13), 2708–2716. DOI: 10.1038/npp.2013.183.
  • Cases, J.; Ibarra, A.; Feuillère, N.; Roller, M.; Sukkar, S. G. Pilot Trial of Melissa Officinalis L. Leaf Extract in the Treatment of Volunteers Suffering from Mild-to-Moderate Anxiety Disorders and Sleep Disturbances. Mediterr. J. Nutr. Metab. 2011, 4(3), 211–218. DOI: 10.1007/s12349-010-0045-4.
  • Patočka, J.; Jakl, J.; Strunecká, A. Expectations of Biologically Active Compounds of the Genus Magnolia in Biomedicine. J. Appl. Biomed. 2006, 4(4), 171–178. DOI: 10.32725/jab.2006.019.
  • Lee, Y.-J.; Lee, Y. M.; Lee, C.-K.; Jung, J. K.; Han, S. B.; Hong, J. T. Therapeutic Applications of Compounds in the Magnolia Family. Pharmacol. Ther. 2011, 130(2), 157–176. DOI: 10.1016/j.pharmthera.2011.01.010.
  • Weeks, B. S. Formulations of Dietary Supplements and Herbal Extracts for Relaxation and Anxiolytic Action: RelarianTM. Med. Sci. Monit 15 . 2009, 256–262.
  • Post-White, J.; Ladas, E. J.; Kelly, K. M. Advances in the Use of Milk Thistle (Silybum Marianum). Integr. Cancer Ther. 2007, 6(2), 104–109. DOI: 10.1177/1534735407301632.
  • Dhawan, K.; Kumar, S.; Sharma, A. Anxiolytic Activity of Aerial and Underground Parts of Passiflora Incarnata. Fitoterapia. 2001, 72(8), 922–926. DOI: 10.1016/S0367-326X(01)00322-7.
  • Dhawan, K.; Kumar, S.; Sharma, A. Anti-Anxiety Studies on Extracts of Passiflora Incarnata Linneaus. J. Ethnopharmacol. 2001, 78(2–3), 165–170. DOI: 10.1016/S0378-8741(01)00339-7.
  • Sampath, C.; Holbik, M.; Krenn, L.; Butterweck, V. Anxiolytic Effects of Fractions Obtained from Passiflora Incarnata L. in the Elevated Plus Maze in Mice. Phytotherapy Res. 2011, 25(6), 789–795. DOI: 10.1002/ptr.3332.
  • Noori Ahmad Abadi, M.; Mortazavi, M.; Kalani, N.; Zare Marzouni, H.; Kooti, W.; Ali-Akbari, S. Effect of Hydroalcoholic Extract of Rosmarinus Officinalis L. Leaf on Anxiety in Mice. J. Evidence-Based Complementary Altern. Med. 2016, 21(4), NP85–NP90. DOI: 10.1177/2156587216642101.
  • Perfumi, M.; Mattioli, L. Adaptogenic and Central Nervous System Effects of Single Doses of 3% Rosavin and 1% Salidroside Rhodiola Rosea L. Extract in Mice. Phytotherapy Res. 2007, 21(1), 37–43. DOI: 10.1002/ptr.2013.
  • Shevtsov, V. A.; Zholus, B. I.; Shervarly, V. I.; Vol’-Skij, V. B.; Korovin, Y. P.; Khristich, M. P.; Roslyakova, N. A.; Wikman, G. A Randomized Trial of Two Different Doses of a SHR-5 Rhodiola Rosea Extract versus Placebo and Control of Capacity for Mental Work. Phytomedicine. 2003, 10(2–3), 95–105. DOI: 10.1078/094471103321659780.
  • Sarris, J.; McIntyre, E.; Camfield, D. A. Plant-Based Medicines for Anxiety Disorders, Part 1: A Review of Preclinical Studies. CNS Drugs. 2013, 27(3), 207–219. DOI: 10.1007/s40263-013-0044-3.
  • Hosseinzadeh, H.; Noraei, N. B. Anxiolytic and Hypnotic Effect of Crocus Sativus Aqueous Extract and Its Constituents, Crocin and Safranal, in Mice. Phytotherapy Res. 2009, 23(6), 768–774. DOI: 10.1002/ptr.2597.
  • Mazidi, M.; Shemshian, M.; Mousavi, S. H.; Norouzy, A.; Kermani, T.; Moghiman, T.; Sadeghi, A.; Mokhber, N.; Ghayour-Mobarhan, M.; Ferns, G. A. A. A Double-Blind, Randomized and Placebo-Controlled Trial of Saffron (Crocus Sativus L.) in the Treatment of Anxiety and Depression. J. Complement. Integr. Med. 2016, 13(2), 195–199. DOI: 10.1515/jcim-2015-0043.
  • Porres-Martínez, M.; González-Burgos, E.; Carretero, M. E.; Gómez-Serranillos, M. P. Protective Properties of Salvia Lavandulifolia Vahl. Essential Oil Against Oxidative Stress-Induced Neuronal Injury. Food Chem. Toxicol. 2015, 80, 154–162. DOI: 10.1016/j.fct.2015.03.002.
  • Ullah, R.; Nadeem, M.; Khalique, A.; Imran, M.; Mehmood, S.; Javid, A.; Hussain, J. Nutritional and Therapeutic Perspectives of Chia (Salvia Hispanica L.): A Review. J. Food Sci. Technol. 2016, 53(4), 1750–1758. DOI: 10.1007/s13197-015-1967-0.
  • Adel, A.; Ikram, R., and Wasi, N. Salvia Hispanica (White Chia): A New Window for Its Antidepressant and Memory Boosting Activity. Pak. J. Pharm. Sci. 2019, 32 1005–1009 .
  • Herrera-Ruiz, M.; GarcíGarcíA-Beltrán, Y.; Mora, S.; Díaz-Véliz, G.; Viana, G. S. B.; Tortoriello, J.; Ramírez, G. Antidepressant and Anxiolytic Effects of Hydroalcoholic Extract from Salvia Elegans. J. Ethnopharmacol. 2006, 107(1), 53–58. DOI: 10.1016/j.jep.2006.02.003.
  • Chan, S.-W. Panax Ginseng Rhodiola Rosea and Schisandra Chinensis. Int. J. Food Sci. Nutr. 2012, 63(sup1), 75–81. DOI: 10.3109/09637486.2011.627840.
  • Wolfson, P.; Hoffmann, D.L. An Investigation into the Efficacy of Scutellaria Lateriflora in Healthy Volunteers. Altern. Ther. Health Med. 2003, 9(2), 74–78.
  • Awad, R.; Arnason, J. T.; Trudeau, V.; Bergeron, C.; Budzinski, J. W.; Foster, B. C.; Merali, Z. Phytochemical and Biological Analysis of Skullcap (Scutellaria Lateriflora L.): A Medicinal Plant with Anxiolytic Properties. Phytomedicine. 2003, 10(8), 640–649. DOI: 10.1078/0944-7113-00374.
  • Liao, Y.-J.; Zhai, H.-F.; Zhang, B.; Duan, T.-X.; Huang, J.-M. Anxiolytic and Sedative Effects of Dehydroeffusol from Juncus Effusus in Mice. Planta Med. 2011, 77(05), 416–420. DOI: 10.1055/s-0030-1250517.
  • Wang, Y.-G.; Wang, Y.-L.; Zhai, H.-F.; Liao, Y.-J.; Zhang, B.; Huang, J.-M. Phenanthrenes from Juncus Effusus with Anxiolytic and Sedative Activities. Nat. Prod. Res. 2012, 26(13), 1234–1239. DOI: 10.1080/14786419.2011.561491.
  • Kim, W. I.; Zhao, B. T.; Zhang, H. Y.; Lee, J. H.; Son, J. K.; Woo, M. H. Quantitative and Pattern Recognition Analyses of Magnoflorine, Spinosin, 6′′′-Feruloyl Spinosin and Jujuboside A by HPLC in Zizyphi Semen. Arch. Pharmacal Res. 2014, 37(9), 1139–1147. DOI: 10.1007/s12272-013-0295-z.
  • Kumar, A.; Garg, R., and Prakash, A. K. Effect of St. John’s Wort (Hypericum Perforatum) Treatment on Restraint Stress-Induced Behavioral and Biochemical Alteration in Mice. BMC Complement. Altern. Med. 2010, 10(18), 1–6. DOI: 10.1186/1472-6882-10-18.
  • Linde, K. St. John’s Wort- an Overview. Forsch Komplementmed. 2009, 16, 146–155. DOI: 10.1159/000209290.
  • Taylor, L. V., and Kobak, K. A. An Open-Label Trial of St. John’s Wort (Hypericum Perforatum) in Obsessive-Compulsive Disorder. J. Clin. Psychiatry. 2000, 61(8), 575–578. DOI: 10.4088/JCP.v61n0806.
  • Davidson, J. R.; Connor, K. M. St. John’s Wort in Generalized Anxiety Disorder: Three Case Reports. J. Clin. Psychopharmacol. 2001, 21(6), 635–636. DOI: 10.1097/00004714-200112000-00026.
  • Volz, H.-P.; Murck, H.; Kasper, S.; Möller, H.-J. St John’s Wort Extract (LI 160) in Somatoform Disorders: Results of a Placebo-Controlled Trial. Psychopharmacology. 2002, 164(3), 294–300. DOI: 10.1007/s00213-002-1171-6.
  • Sarris, J. St. John’s Wort for the Treatment of Psychiatric Disorders. Psychiatr. Clin. N. Am. 2013, 36(1), 65–72. DOI: 10.1016/j.psc.2013.01.004.
  • Banerjee, S.; Chatterjee, J. Efficient Extraction Strategies of Tea (Camellia Sinensis) Biomolecules. J. Food Sci. Technol. 2015, 52(6), 3158–3168. DOI: 10.1007/s13197-014-1487-3.
  • Dufresne, C. J.; Farnworth, E. R. A Review of Latest Research Findings on the Health Promotion Properties of Tea. J. Nutr. Biochem. 2001, 12(7), 404–421. DOI: 10.1016/S0955-2863(01)00155-3.
  • Williams, J. L.; Everett, J. M.; D’-Cunha, N. M.; Sergi, D.; Georgousopoulou, E. N.; Keegan, R. J.; McKune, A. J.; Mellor, D. D.; Anstice, N.; Naumovski, N. The Effects of Green Tea Amino Acid L-Theanine Consumption on the Ability to Manage Stress and Anxiety Levels: A Systematic Review. Plant Foods Hum. Nutr. 2020, 75(1), 12–23. DOI: 10.1007/s11130-019-00771-5.
  • Unno, K.; Hara, A.; Nakagawa, A.; Iguchi, K.; Ohshio, M.; Morita, A.; Nakamura, Y. Anti-Stress Effects of Drinking Green Tea with Lowered Caffeine and Enriched Theanine, Epigallocatechin and Arginine on Psychosocial Stress Induced Adrenal Hypertrophy in Mice. Phytomedicine. 2016, 23(12), 1365–1374. DOI: 10.1016/j.phymed.2016.07.006.
  • Murphy, K.; Kubin, Z. J.; Shepherd, J. N.; Ettinger, R. H. Valeriana Officinalis Root Extracts Have Potent Anxiolytic Effects in Laboratory Rats. Phytomedicine. 2010, 17(8–9), 674–678. DOI: 10.1016/j.phymed.2009.10.020.
  • Hattesohl, M.; Feistel, B.; Sievers, H.; Lehnfeld, R.; Hegger, M.; Winterhoff, H. Extracts of Valeriana Officinalis L. S.L. Show Anxiolytic and Antidepressant Effects but Neither Sedative nor Myorelaxant Properties. Phytomedicine. 2008, 15(1–2), 2–15. DOI: 10.1016/j.phymed.2007.11.027.
  • Baretta, I. P.; Felizardo, R. A.; Bimbato, V. F.; dos Santos, M. G. J.; Kassuya, C. A. L.; Gasparotto Junior, A.; da Silva, C. R.; de Oliveira, S. M.; Ferreira, J.; Andreatini, R. Anxiolytic-Like Effects of Acute and Chronic Treatment with Achillea Millefolium L. Extract. J. Ethnopharmacol. 2012, 140(1), 46–54. DOI: 10.1016/j.jep.2011.11.047.
  • Pirzad Jahromi, G.; Imani, E.; Nasehi, M.; Shahriari, A. Effect of Achillea Millefolium Aqueous Extract on Memory Deficit and Anxiety Caused by Stroke in Ovariectomized Rats. J. Herbmed Pharmacol. 2019, 8(2), 153–159. DOI: 10.15171/jhp.2019.24.
  • Lim, C. H.; Kangas, B., and Bergman, J. The Utility of Psilocybin in Managing Anxiety and Depression in Cancer Patients. J. Young Invest 35 2 45–49 . 2018.
  • Lattimore, K. A.; Donn, S. M.; Kaciroti, N.; Kemper, A. R.; Neal, C. R.; Vazquez, D. M. Selective Serotonin Reuptake Inhibitor (SSRI) Use During Pregnancy and Effects on the Fetus and Newborn: A Meta-Analysis. J. Perinatol. 2005, 25(9), 595–604. DOI: 10.1038/sj.jp.7211352.
  • Chen, X.; van Gerven, J.; Cohen, A.; Jacobs, G. Human Pharmacology of Positive GABA-A Subtype-Selective Receptor Modulators for the Treatment of Anxiety. Acta Pharmacol. Sin. 2019, 40(5), 571–582. DOI: 10.1038/s41401-018-0185-5.
  • Panossian, A. Understanding Adaptogenic Activity: Specificity of the Pharmacological Action of Adaptogens and Other Phytochemicals: Mechanisms of Adaptogenic Activity of Botanicals. Ann. Ny. Acad. Sci. 2017, 1401(1), 49–64. DOI: 10.1111/nyas.13399.
  • McKenna, D. J. Clinical Investigations of the Therapeutic Potential of Ayahuasca: Rationale and Regulatory Challenges. Pharmacol. Ther. 2004, 102(2), 111–129. DOI: 10.1016/j.pharmthera.2004.03.002.
  • Garner, L. F.; Klinger, J. D. Some Visual Effects Caused by the Beverage Kava. J. Ethnopharmacol. 1985, 13(3), 307–311. DOI: 10.1016/0378-8741(85)90076-5.
  • Aporosa, A. S.; Atkins, M.; Brunton, R. Kava Drinking in Traditional Settings: Towards Understanding Effects on Cognitive Function. Hum. Psychopharmacol. Clin. Exp. 2020, 35(2), e2725. DOI: 10.1002/hup.2725.
  • Li, L.-T.; Wang, S.-H.; Ge, H.-Y.; Chen, J.; Yue, S.-W.; Yu, M. The Beneficial Effects of the Herbal Medicine Free and Easy Wanderer Plus (FEWP) and Fluoxetine on Post-Stroke Depression. J. Altern. Complementary Med. 2008, 14(7), 841–846. DOI: 10.1089/acm.2008.0010.
  • Wang, H.-N.; Peng, Y.; Tan, Q.-R.; Wang, H.-H.; Chen, Y.-C.; Zhang, R.-G.; Wang, Z.-Z.; Guo, L.; Liu, Y.; Zhang, Z.-J. Free and Easy Wanderer Plus (FEWP), a Polyherbal Preparation, Ameliorates PTSD-Like Behavior and Cognitive Impairments in Stressed Rats. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 2009, 33(8), 1458–1463. DOI: 10.1016/j.pnpbp.2009.07.031.
  • Ikarashi, Y.; Yuzurihara, M.; Sakakibara, I.; Takahashi, A.; Ishimaru, H.; Maruyama, Y. Effects of an Oriental Herbal Medicine, “Saiboku-to”, and Its Constituent Herbs on Compound 48/80-Induced Histamine Release from Peritoneal Mast Cells in Rats. Phytomedicine. 2001, 8(1), 8–15. DOI: 10.1078/0944-7113-00012.
  • Maruyama, Y.; Kuribara, H.; Morita, M.; Yuzurihara, M.; Weintraub, S. T. Identification of Magnolol and Honokiol as Anxiolytic Agents in Extracts of Saiboku-to, an Oriental Herbal Medicine. J. Nat. Prod. 1998, 61(1), 135–138. DOI: 10.1021/np9702446.
  • Kuribara, H.; Kishi, E.; Hattori, N.; Okada, M.; Maruyama, Y. The Anxiolytic Effect of Two Oriental Herbal Drugs in Japan Attributed to Honokiol from Magnolia Bark. J. Pharm. Pharmacol. 2000, 52, 1425–1429. DOI: 10.1211/0022357001777432.
  • Yuzurihara, M.; Ikarashi, Y.; Ishige, A.; Sasaki, H.; Maruyama, Y. Anxiolytic-Like Effect of Saiboku-to, an Oriental Herbal Medicine, on Histaminergics-Induced Anxiety in Mice. Pharmacol. Biochem. Behav. 2000, 67(3), 489–495. DOI: 10.1016/S0091-3057(00)00393-2.
  • Iwasaki, K.; Wang, Q.; Nakagawa, T.; Suzuki, T.; Sasaki, H. The Traditional Chinese Medicine Banxia Houpo Tang Improves Swallowing Reflex. Phytomedicine. 1999, 6(2), 103–106. DOI: 10.1016/S0944-7113(99)80043-9.
  • Kaneko, A.; Cho, S.; Hirai, K.; Okabe, T.; Iwasaki, K.; Nanba, Y.; Ouchi, Y.; Cyong, J.-C. Hange-Koboku-To, a Kampo Medicine, Modulates Cerebral Levels of 5-HT (5-Hydroxytryptamine), NA (Noradrenaline) and DA (Dopamine) in Mice. Phytotherapy Res. 2005, 19(6), 491–495. DOI: 10.1002/ptr.1669.
  • Naito, T.; Itoh, H.; Takeyama, M. Effects of Hange-Koboku-to (Banxia-Houpo-Tang) on Neuropeptide Levels in Human Plasma and Saliva. Biol. Pharm. Bull. 2003, 26(11), 1609–1613. DOI: 10.1248/bpb.26.1609.
  • Shimoyama, Y.; Hosaka, H.; Kuribayashi, S.; Kawamura, O.; Kusano, M. Herbal Medicine. In Functional Dyspepsia: Evidences in Pathophysiology and Treatment; Tominaga, K. and Kusunoki, H., Eds.; Springer: Singapore, 2018; pp. 147–152.
  • Aslanyan, G.; Amroyan, E.; Gabrielyan, E.; Nylander, M.; Wikman, G.; Panossian, A. Double-Blind, Placebo-Controlled, Randomised Study of Single Dose Effects of ADAPT-232 on Cognitive Functions. Phytomedicine. 2010, 17(7), 494–499. DOI: 10.1016/j.phymed.2010.02.005.
  • Ibarra, A.; Feuillere, N.; Roller, M.; Lesburgere, E.; Beracochea, D. Effects of Chronic Administration of Melissa Officinalis L. Extract on Anxiety-Like Reactivity and on Circadian and Exploratory Activities in Mice. Phytomedicine. 2010, 17(6), 397–403. DOI: 10.1016/j.phymed.2010.01.012.
  • AVIDEKEL | CBD. https://tikunolam.com/avidekel-cbd-2-2/ (accessed Jun 9, 2021).
  • Small, E. Cannabis : A Complete Guide; Boca Raton: CRC Press, 2016.
  • Lima, N. G. P. B.; De Sousa, D. P.; Pimenta, F. C. F.; Alves, M. F.; De Souza, F. S.; Macedo, R. O.; Cardoso, R. B.; de Morais, L. C. S. L.; Melo Diniz, M. D. F. F.; de Almeida, R. N. Anxiolytic-Like Activity and GC–MS Analysis of (R)-(+)-Limonene Fragrance, a Natural Compound Found in Foods and Plants. Pharmacol. Biochem. Behav. 2013, 103(3), 450–454. DOI: 10.1016/j.pbb.2012.09.005.
  • Spiers, J. G.; Chen, H.-J.-C.; Lavidis, N. A. Stress Alleviating Plant-Derived ‘Green Odors’: Behavioral, Neurochemical and Neuroendocrine Perspectives in Laboratory Animals. Phytochem. Rev. 2015, 14(5), 713–725. DOI: 10.1007/s11101-014-9371-3.
  • Public Health Agency of Canada. Mood and Anxiety Disorders in Canada. https://www.canada.ca/en/public-health/services/publications/diseases-conditions/mood-anxiety-disorders-canada.html (accessed Aug 20, 2019).
  • Khan, I. N.; Sarker, M. I.; Ajrin, M. Sedative and Anxiolytic Effects of Ethanolic Extract of Calotropis Gigantea (Asclepiadaceae) Leaves. Asian Pac. J. Trop. Biomed. 2014, 4, S400–S404. DOI: 10.12980/APJTB.4.2014C1147.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.